Read the Research

On 19 October 2026 Veradermics reported topline results from Study ‘304’, the second placebo-controlled Phase 3 trial of VDPHL01, its extended-release oral m...

Hair cloning is the most durable promise in hair loss: take a few of your own follicles, multiply them in a lab, and put back thousands. It has been “a few y...

PP405 is a topical drug that takes an unusual approach to hair loss. Instead of blocking androgens or widening blood vessels, it is designed to reactivate ha...

Minoxidil plus finasteride is a pairing that is often recommended, and it has one awkward feature: the finasteride is usually a tablet, with the whole-body e...

Hair-loss hormones may not act on the follicle directly. In the model behind EPI-005, DHT and testosterone first tell fibroblasts, the cells around the folli...

Two opposite claims circulate about copper peptides and skin colour. One says GHK-Cu fades dark spots and evens out tone. The other says that because copper ...

Matrixyl is one of the most recognisable names on a peptide serum label, and GHK-Cu is the copper peptide that keeps turning up beside it in threads asking w...

If you have been on finasteride and minoxidil for a year and are still losing ground, the options for what comes next are different in kind. Some change the ...

Search for new hair loss treatments and you tend to find two kinds of page: press releases announcing breakthroughs, and forum threads asking when they will ...

When Cosmo Pharmaceuticals announced its Phase 3 results for clascoterone 5% solution (Breezula) in December 2025, the release described the drug as blocking...